Literature DB >> 26155548

Novel Cytogenetic Aberrations in a Patient of Chronic Myeloid Leukemia with Blast Crisis.

Bhoumik Shah1, Smeeta Gajendra2, Ritu Gupta3, Atul Sharma4.   

Abstract

Chronic myeloid leukaemia (CML) is a clonal haematological disease which is characterized by a diagnostic karyotypic abnormality t (9;22)(q34;q11) called as Philadelphia (Ph) chromosome. Occurrence of additional chromosomal abnormalities besides the Ph chromosome is defined as clonal evolution (CE) and considered to be a marker of disease progression. A 67-year-old male who was initially evaluated at a private hospital where a diagnosis of acute promyelocytic leukaemia was made on bone marrow aspirate with ambiguous RT-PCR report referred to our centre for further evaluation and treatment. On conventional karyotyping, Ph chromosome along with translocations t(5;13)(q12;p13), t(15;20)(q22;p13) and monosomy 13 was observed in all 20 metaphases. A final diagnosis of CML-myeloid blast crisis with complex cytogenetics was made. Patient succumbed to death within one month of initiation of imatinib therapy.

Entities:  

Keywords:  Complex cytogenetics; Monosomy 13; t(15;20)(q22;p13); t(5;13)(q12;p13)

Year:  2015        PMID: 26155548      PMCID: PMC4484140          DOI: 10.7860/JCDR/2015/12284.5940

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  12 in total

1.  Assignment of two human cell cycle genes, CDC25C and CCNB1, to 5q31 and 5q12, respectively.

Authors:  H Sartor; F Ehlert; K H Grzeschik; R Müller; S Adolph
Journal:  Genomics       Date:  1992-07       Impact factor: 5.736

2.  Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV.

Authors:  Alice Fabarius; Armin Leitner; Andreas Hochhaus; Martin C Müller; Benjamin Hanfstein; Claudia Haferlach; Gudrun Göhring; Brigitte Schlegelberger; Martine Jotterand; Andreas Reiter; Susanne Jung-Munkwitz; Ulrike Proetel; Juliana Schwaab; Wolf-Karsten Hofmann; Jörg Schubert; Hermann Einsele; Anthony D Ho; Christiane Falge; Lothar Kanz; Andreas Neubauer; Michael Kneba; Frank Stegelmann; Michael Pfreundschuh; Cornelius F Waller; Karsten Spiekermann; Gabriela M Baerlocher; Michael Lauseker; Markus Pfirrmann; Joerg Hasford; Susanne Saussele; Rüdiger Hehlmann
Journal:  Blood       Date:  2011-10-28       Impact factor: 22.113

Review 3.  Treatment of chronic myeloid leukemia in blast crisis.

Authors:  R Hehlmann; S Saussele
Journal:  Haematologica       Date:  2008-12       Impact factor: 9.941

4.  [Multiplex fluorescence in situ hybridization for detecting complex chromosomal aberrations in chronic myeloid leukemia in blast crisis].

Authors:  Yu Zhu; Jian-Yong Li; Wei Xu; Hai-Rong Qiu; Li-Juan Chen; Jin-Lan Pan; Yun-Feng Shen; Yong-Quan Xue
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2007-07

5.  Fluorescence in situ hybridization investigation of cutaneous lesions in acute promyelocytic leukemia.

Authors:  Joanna E Wrede; Uma Sundram; Sabine Kohler; Athena M Cherry; Daniel A Arber; Tracy I George
Journal:  Mod Pathol       Date:  2005-12       Impact factor: 7.842

6.  The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML.

Authors:  Michael E O'Dwyer; Michael J Mauro; Gwen Kurilik; Motomi Mori; Suzanne Balleisen; Susan Olson; Ellen Magenis; Renaud Capdeville; Brian J Druker
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

Review 7.  The Biology of CML blast crisis.

Authors:  Jerald P Radich
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2007

8.  Significance of cytogenetic clonal evolution in chronic myelogenous leukemia.

Authors:  A Majlis; T L Smith; M Talpaz; S O'Brien; M B Rios; H M Kantarjian
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

9.  PML targeting eradicates quiescent leukaemia-initiating cells.

Authors:  Keisuke Ito; Rosa Bernardi; Alessandro Morotti; Sahoko Matsuoka; Giuseppe Saglio; Yasuo Ikeda; Jacalyn Rosenblatt; David E Avigan; Julie Teruya-Feldstein; Pier Paolo Pandolfi
Journal:  Nature       Date:  2008-05-11       Impact factor: 49.962

10.  miR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein level.

Authors:  Shen-meng Gao; Chong-yun Xing; Chi-qi Chen; Si-si Lin; Pei-hong Dong; Fu-jun Yu
Journal:  J Exp Clin Cancer Res       Date:  2011-12-01
View more
  1 in total

1.  Double Philadelphia Chromosomes- A Rare, Yet an Important Cytogenetic Phenomenon of Prognostic Significance in De Novo Acute Lymphoblastic Leukemia.

Authors:  Shanthala Siddappa; Syed Adil Hassan; Kavitha B Lingappa; L K Rajeev; M Padma; Lokanatha Dasappa
Journal:  Indian J Hematol Blood Transfus       Date:  2022-04-16       Impact factor: 0.915

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.